Skip to main content

Table 4 Ventilatory support and laboratory parameters during home oxygen treatment and monitoring program

From: Rapid implementation of home oxygen treatment and remote monitoring for COVID-19 patients at the verge of the Omicron wave in Turku, Finland

 

Median value or n/N

Q1-Q3 or %

Duration of oxygen treatment, days

19

13 – 18

Duration of monitoring, days

18

10 – 22

Oxygen flow at entry in the program, L/min

2

1 – 2

Oxygen flow at day 7, L/min

2

1 – 2.5

Last leukocytes count before entry in the program, × 109/L

7.5

6.4 – 10.1

Leukocyte count at day 6, × 109/L

9.2

6.7 – 15.1

Last C-reactive protein before entry in the program, mg/L

14

3 – 33

C-reactive protein at day 6, mg/L

5.0

2.0 – 20

Last ferritin before entry in the program, µg/L

984

495 – 1268

Ferritin at day 6, µg/L

802

362 – 1229

Last D-dimer before entry in the program, mg/L

0.5

0.1 – 1.7

D-dimer at day 6, mg/L

0.5

0.3 – 0.5